Expression of complement regulatory protein on porcine endogenous retrovirus (PERV) depends on molecular size

Oldmixon, 2002, Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine, J Virol, 76, 3045, 10.1128/JVI.76.6.3045-3048.2002 Blusch, 2002, Pig endogenous retroviruses and xenotransplantation, Xenotransplantation, 9, 242, 10.1034/j.1399-3089.2002.01110.x Patience, 1997, Infection of human cells by an endogenous retrovirus of pigs, Nat Med, 3, 282, 10.1038/nm0397-282 Wilson, 1998, Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells, J Virol, 72, 3082, 10.1128/JVI.72.4.3082-3087.1998 Ericsson, 2003, Identification of receptors for pig endogenous retrovirus, Proc Natl Acad Sci U S A, 100, 6759, 10.1073/pnas.1138025100 Martina, 2006, Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection, J Virol, 80, 3135, 10.1128/JVI.80.7.3135-3146.2006 Paradis, 1999, Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group, Science, 285, 1236, 10.1126/science.285.5431.1236 Cooper, 2003, Clinical xenotransplantion—how close are we?, Lancet, 362, 557, 10.1016/S0140-6736(03)14118-9 Miyagawa, 1988, The mechanism of discordant xenograft rejection, Transplantation, 46, 825, 10.1097/00007890-198812000-00007 Takefman, 2002, Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation, J Virol, 76, 1999, 10.1128/JVI.76.4.1999-2002.2002 Magre, 2004, Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha (1-3) galactosyl epitope, J Virol, 78, 5812, 10.1128/JVI.78.11.5812-5819.2004 Hazama, 2005, The effect of complement regulatory protein expression on pig endothelial cells to porcine endogenous retrovirus lyses by human sera, Transplant Proc, 37, 503, 10.1016/j.transproceed.2005.01.084 Spear, 1995, Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV), J Immunol, 155, 4376, 10.4049/jimmunol.155.9.4376 Saifuddin, 1997, Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction, J Gen Virol, 78, 1907, 10.1099/0022-1317-78-8-1907 Saifuddin, 1995, Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1, J Exp Med, 182, 501, 10.1084/jem.182.2.501 Miyagawa, 1994, Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAF hybrid, on complement-mediated swine endothelial cell lysis, Transplantation, 58, 834, 10.1097/00007890-199410000-00015 Kuttner-Kondo, 2001, Characterization of the active sites in decay-accelerating factor, J Immunol, 167, 2164, 10.4049/jimmunol.167.4.2164 Miyagawa, 1993, Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes, Scand J Immunol, 38, 37, 10.1111/j.1365-3083.1993.tb01691.x Kurihara, 2003, Sensitivity to human serum of gammaretroviruses produced from pig endothelial cells transduced with glycosyltransferase genes, Xenotransplantation, 10, 562, 10.1034/j.1399-3089.2003.00056.x Niwa, 1991, Efficient selection for high-expression transfectants with a novel eukaryotic vector, Gene, 108, 193, 10.1016/0378-1119(91)90434-D Fukuta, 2003, Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis, Xenotransplantation, 10, 132, 10.1034/j.1399-3089.2003.01120.x Miyagawa, 2004, Delta-short consensus repeat 4-decay accelerating factor (DAF:CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis, J Immunol, 173, 3945, 10.4049/jimmunol.173.6.3945 Komoda, 2004, A study of the xenoantigenicity of adult pig islets cells, Xenotransplantation, 11, 237, 10.1111/j.1399-3089.2004.00121.x Miyagawa S, Yamamoto A, Matsunami K, Wang D, Takama Y, Ueno T, et al. Complement regulation in the GalT KO era. Xenotransplantation 2010;17:61–70. Miyagawa, 2006, Effect of tandem forms of DAF(CD55) on complement-mediated xenogeneic cell lysis, Xenotransplantation, 13, 433, 10.1111/j.1399-3089.2006.00331.x Okura, 2008, Differential human serum-mediated neutralization of PERV released from pig cells transfected with variants of hDAF, Xenotransplantation, 15, 365, 10.1111/j.1399-3089.2008.00496.x Miyagawa, 2006, A novel strategy for preventing PERV transmission to human cells by remodeling the viral envelope glycoprotein, Xenotransplantation, 13, 258, 10.1111/j.1399-3089.2006.00313.x